ArticleThe European respiratory journal2022
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.
Abstract readEditorialComment
In one paragraph
Article in The European respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Recent Advances in the Design of Inhibitors Targeting the Viral Entry and Replication of the SARS-CoV-2 Virus, Driven by In Silico Approaches.Molecules (Basel, Switzerland) · 2026Review
- Chronic Respiratory Diseases: The Stories You Don't Want to Miss.Medicina (Kaunas, Lithuania) · 2026Article
- Article
- Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10.International journal of molecular sciences · 2025Article
- The association between vital signs at hospital admission and adverse outcomes in patients with COVID-19: a retrospective cohort study.Frontiers in medicine · 2025Article
- Article
- SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial.ERJ open research · 2024Article
- [Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023Article
- Article
- A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection.Thrombosis journal · 2023Article
- Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?Pulmonary therapy · 2023Review
- Serial lung ultrasound in monitoring viral pneumonia: the lesson learned from COVID-19.ERJ open research · 2023Article
- Antiviral Therapy of COVID-19.International journal of molecular sciences · 2023Review
- Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumonia.ERJ open research · 2023Article
- Host-Based Treatments for Severe COVID-19.Current issues in molecular biology · 2023Review
- Treating COVID-19: Targeting the Host Response, Not the Virus.Life (Basel, Switzerland) · 2023Review
- Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023Article
- Article
- Management of moderate severity outpatients with COVID-19 disease: Proposed criteria and algorithm for initiation of antiviral treatment.Respirology (Carlton, Vic.) · 2023Article
- Pharmacological approaches to pulmonary fibrosis following COVID-19.Frontiers in pharmacology · 2023Review
Corrections and comments
- Comment on
Authors and funding
19 authors.
Nicolas RocheRespiratory Medicine, Cochin Hospital, APHP Centre-University of Paris, Cochin Institute (INSERM UMR1016), Paris, France.
Megan L CrichtonSchool of Medicine, University of Dundee, Dundee, UK.
Pieter C GoeminneDepartment of Respiratory Medicine, AZ Nikolaas, Sint-Niklaas, Belgium.
Bin CaoDepartment of Respiratory and Critical Care Medicine, Clinical Microbiology and Infectious Disease Lab, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Science, National Clinical Research Center of Respiratory Diseases, Beijing, China.
Marc HumbertService de Pneumologie et Soins Intensifs, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Inserm UMR_S 999, Le Kremlin Bicêtre, France.ORCID 0000-0003-0703-2892
Michal ShteinbergPulmonology institute and CF Center, Carmel Medical Center and the Technion-Israel Institute of Technology, Haifa, Israel.ORCID 0000-0002-0432-3398
Katerina M AntoniouLaboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, School of Medicine, University of Crete, Heraklion, Greece.
Charlotte Suppli UlrikDepartment of Respiratory Medicine, Copenhagen University Hospital-Hvidovre Hospital, Hvidovre, Denmark.ORCID 0000-0001-8689-3695
Helen ParksEuropean Lung Foundation, Sheffield, UK.
Chen WangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center of Respiratory Diseases, Beijing, China.
Thomas VandendriesscheKU Leuven Libraries - 2Bergen - Learning Centre Désiré Collen, Leuven, Belgium.
Jieming QuDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai, China.
Daiana StolzClinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland.
Christopher BrightlingInstitute for Lung Health, Leicester NIHR BRC, University of Leicester, Leicester, UK.
Tobias WelteMedizinische Hochschule Hannover, Hannover, Germany.ORCID 0000-0002-9947-7356
Stefano AlibertiUniversity of Milan, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-0090-4531
Anita K SimondsRespiratory and Sleep Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Thomy ToniaInstitute of Social and Preventive Medicine, University Bern, Bern, Switzerland.
James D ChalmersSchool of Medicine, University of Dundee, Dundee, UK jchalmers@dundee.ac.uk.ORCID 0000-0001-5514-7868
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19TuberculosisAdultBiomarkersHumansRespiratory SystemSARS-CoV-2Biomarkers
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.